We are pleased to announce that Yuki Hasegawa, Co-Head of our Business Development Team, has been appointed as Vice Chairperson and General Manager of the Business Development, effective October 1, 2023.

【Yuki’s Biography】
After earning a PhD in genomic science, Dr. Yuki Hasegawa joined the Center for Genomic Sciences in RIKEN as a researcher in 2007 and worked on projects of gene transcription regulatory networks of various cells including iPS cells. After working as a deputy team leader in the Research Center for Life Science Technology Platforms in RIKEN, she joined Asahi Kasei Corporation in 2014 and gained experience in project initiation and other activities within the regenerative medicine research team. In 2016, she joined Whiz Partners, and she has been Head of Healthcare Investment since 2021. In 2022, she was appointed as a Co-head of Business Development Team in ARCALIS. Dr. Hasegawa also holds concurrent positions as an outside director at ActualEyes Inc. and NANO MRNA Co., Ltd.